AUTL AUTOLUS THERAPEUTICS PLC US FDA Inspections 8-K Filing 2023 - FDA Submission Autolus Therapeutics plc submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for obecabtagene autoleucel (obe-cel).Get access to all SEC 8-K filings of the AUTOLUS THERAPEUTICS PLC